Sector: Life Sciences

Latest content

Trade secrets are a TRIPs waiver target and that is a big problem

Disappointment with last year’s WTO agreement on suspending patent rights to secure covid-19 vaccine supplies has led campaigners to intensify calls for a new agreement that would include know-how

05 October 2023

Inventor firm’s $339M windfall from Google tops ranking of US patent jury verdicts in Q3

Touchstream Technologies’ victory is one of 17 jury verdicts that issued in 2023’s third quarter and 59% of them favoured patentees – but Q3 damages values dropped compared to Q1 and Q2

02 October 2023

Trade secret litigation soars in the life sciences industry

Trade secrets surge ahead in the age of the DTSA due to evolving IP terrain and rising patent litigation risks

02 October 2023

Does the impact of Markman orders vary by technology complexity?

Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?

27 September 2023

Three things to know about the US government’s new strategy for standards development

Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP

20 September 2023

Unified Patent Court grants preliminary injunction to 10x Genomics

A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries

19 September 2023

Patent transactions in Q2 2023

Featured in Secondary Market Activity

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

15 September 2023

10x Genomics strikes blow against NanoString in the US

IAM explores the American portions of a spat whose UPC and German actions have hogged the limelight

14 September 2023

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

13 September 2023

$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

12 September 2023

Unlock unlimited access to all IAM content